The stock price of Medtronic Plc (NYSE: MDT) has surged by 0.92 when compared to previous closing price of 87.27, but the company has seen a 0.71% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-15 that Medtronic remains a dependable dividend aristocrat, but its long-term total shareholder returns lag significantly behind peers like Johnson & Johnson and Stryker. Despite a solid 2025 performance, the stock’s recent gains stem from a low base, and it still trades well below its 2021 highs. Earnings growth is steady but uninspiring, with margin pressure and tariff risks highlighting operational challenges versus higher-quality competitors.
Is It Worth Investing in Medtronic Plc (NYSE: MDT) Right Now?
The price-to-earnings ratio for Medtronic Plc (NYSE: MDT) is above average at 24.35x. The 36-month beta value for MDT is also noteworthy at 0.81. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5 rating it as “overweight,” 13 rating it as “hold,” and 1 rating it as “sell.”
The public float for MDT is 1.28B, and at present, short sellers hold a 0.62% of that float. The average trading volume of MDT on June 16, 2025 was 7.94M shares.
MDT’s Market Performance
The stock of Medtronic Plc (MDT) has seen a 0.71% increase in the past week, with a 2.28% rise in the past month, and a -5.65% fall in the past quarter. The volatility ratio for the week is 0.91%, and the volatility levels for the past 30 days are at 1.41% for MDT. The simple moving average for the past 20 days is 3.39% for MDT’s stock, with a 0.94% simple moving average for the past 200 days.
Analysts’ Opinion of MDT
Citigroup, on the other hand, stated in their research note that they expect to see MDT reach a price target of $107, previously predicting the price at $92. The rating they have provided for MDT stocks is “Buy” according to the report published on March 04th, 2025.
RBC Capital Mkts gave a rating of “Outperform” to MDT, setting the target price at $105 in the report published on October 10th of the previous year.
MDT Trading at 4.42% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.49% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDT starting from Salmon Sean, who proposed sale 18,378 shares at the price of $86.81 back on Jun 06 ’25. After this action, Salmon Sean now owns shares of Medtronic Plc, valued at $1,595,469 using the latest closing price.
Wall Brett A., the EVP & Pres Neuroscience of Medtronic Plc, sale 12,437 shares at $90.00 during a trade that took place back on Jan 24 ’25, which means that Wall Brett A. is holding 40,979 shares at $1,119,330 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.47 for the gross margin
The net margin for Medtronic Plc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 9.49, with 5.13 for asset returns.
Based on Medtronic Plc (MDT), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.59. The interest coverage ratio of the stock is 8.17.
Currently, EBITDA for the company is 5.96 billion with net debt to EBITDA at 3.16. When we switch over and look at the enterprise to sales, we see a ratio of 4.15. The receivables turnover for the company is 5.15for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.
Conclusion
In summary, Medtronic Plc (MDT) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
